Warning letter
Clinical Pharmacies, Inc.: warning letter of Apr 27, 2004
FDA warning letter UCM146360 · Los Angeles District Office
Key facts
| Reference number | UCM146360 |
|---|---|
| Company | Clinical Pharmacies, Inc. |
| Subject | Quality System Regulation/Adulterated |
| Issue date | Apr 27, 2004 |
| Posted date | Apr 27, 2004 |
| Issuing office | Los Angeles District Office |
| Product type | Devices |
| CFR sections cited | 803, 820, 820.5, 820.40 |
| Country | 3 |
| Inspection city | Huntington Beach |
| Inspection ZIP | 92646-7068 |
| Inspection start date | Feb 19, 2004 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: